Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

This publication has 33 references indexed in Scilit:

• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
  Circulation, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial Infarction
  New England Journal of Medicine, 1989
• Plasminogen activator italian multicenter study (PAIMS): Comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-pa) with intravenous streptokinase in acute myocardial infarction
  Journal of the American College of Cardiology, 1989
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
  Circulation, 1988
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986
• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
  Circulation, 1984